Thus, in tendinopathy, FHL2 overexpression may primarily suppress inflammatory angiogenesis via its anti-inflammatory effects, thereby improving perfusion and promoting repair, potentially mediated by the YAP1/sFRP2 axis. This evidence concerns the gene SFRP2 and disease of the tendon.